Lerner Research Institute

Home to basic, translational and clinical research at Cleveland Clinic, a top U.S. hospital.



CYCLE-AD Trial: Testing High-Intensity Exercise to Stave Off Alzheimer’s Disease

With a new $6.7 million grant from NIH, Drs. Alberts and Rao will test if home-based, high-intensity cycling may help prevent sedentary adults who carry the highest risk Alzheimer’s-related gene variant from developing the disease.

Read More


Researchers Identify Protector of Intestinal Barrier

Dr. Ivanov and his team have clarified the essential protective role of Β-actin in regulating the epithelial barrier and intestinal inflammation.

Read More


Researchers Engineer Novel Disease Model to Develop New Ulcerative Colitis Drugs

Dr. Huang developed an innovative patient-derived model of the chronic inflammatory bowel disease that mirrors the disease’s complexity better than others currently available and identified the protein CXCL8 as an actionable drug target.

Read More

Institute News

COVID-19: Our Response

The best and brightest scientists, researchers and clinicians are working together to study treatments and prevention strategies to overcome the novel coronavirus (SARS-CoV-2) causing COVID-19. Explore our latest research news and discoveries.

Learn More

Accelerating Discoveries to Patients

Working together with Cleveland Clinic physicians, our scientists are discovering the treatments of tomorrow. While many spend their days working at the laboratory bench, their inspiration can be found at the patient bedside.

Education & Training

Postdoctoral Program

Train on the cutting-edge of research and join our thriving postdoc association.

Learn More

Molecular Medicine PhD Program

Earn your PhD through our unique program that combines basic science and medical knowledge.

Learn More

Graduate Programs

Earn your PhD through our joint program with local universities.

Learn More